KPT-8602
KCP-8602-801
Phase 2 small_molecule completed
Quick answer
KPT-8602 for Relapsed/Refractory Multiple Myeloma (RRMM) is a Phase 2 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Relapsed/Refractory Multiple Myeloma (RRMM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed